"India One Of The Largest Contributors...": WHO Chief Scientist On Covid Efforts
NDTV
"World Health Organisation (WHO) has set up a global solidarity platform because it recognised that multiple small clinical trials will be done but will not be leading conclusive results," WHO Chief Scientist Dr Soumya Swaminathan said during the opening ceremony of the seminar of PANEX-21.
WHO Chief Scientist Dr Soumya Swaminathan today said India is one of the largest contributors of the global solidarity trial that is aimed to provide robust results on whether a drug can save lives in patients hospitalised with severe or critical COVID-19.
"World Health Organisation (WHO) has set up a global solidarity platform because it recognised that multiple small clinical trials will be done but will not be leading conclusive results," Dr Swaminathan said during the opening ceremony of the seminar of PANEX-21.
WHO Chief Scientist stressed that a pandemic requires multicountry and collaborative platform trials. "...an adaptive design where we bring on drugs to test...do it in very large sample size, an look at endpoints which are of public health importance like mortality," she said.
"India is one of the largest contributors of the global solidarity trial coordinated by the Indian Council of Medical Research (ICMR) but occurring in countries across countries," she added.
